Amyris is a leading synthetic biotechnology company active in the Clean Health and Beauty markets. It produces environmentally-friendly products that are made with sustainable, synthetic biology ingredients.
Using sugarcane fermentation, the company converts basic plant sugars into rare bioidentical molecules.
Amyris’ science and technology delivers natural ingredients for sustainable products like anti-wrinkle skincare, a zero-calorie sweetener, a life-saving medication, a fine fragrance, or a polymer that makes electronic circuits more effective.
This new standard for clean chemistry is set by biomanufacturing and clean ingredients.
Total revenue increased by 74% to $52.3 million for the three months ended June 30, 2021 compared to the same period in 2020. Net cash provided by operating activities was $30.2 million, consisting primarily of a $274.6 million net loss.
We delivered record underlying revenue driven by record consumer revenue while significantly improving margins year-over-year. Two of our homegrown clean beauty brands, Biossance and Pipette, delivered record revenue with Biossance doubling revenue versus the prior year quarter.